These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6109173)

  • 1. Des-Tyr1-gamma-endorphin in schizophrenia.
    Emrich HM; Zaudig M; v Zerssen D; Herz A; Kissling W
    Lancet; 1980 Dec 20-27; 2(8208-8209):1364-5. PubMed ID: 6109173
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of [Des-Tyr1]-gamma-endorphin in schizophrenia.
    Emrich HM; Zaudig M; v Zerssen D; Kissling W; Dirlich G; Herz A
    Mod Probl Pharmacopsychiatry; 1981; 17():279-86. PubMed ID: 7329421
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
    van Ree JM; Verhoeven WM; de Wied D; van Praag HM
    Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.
    Verhoeven WM; van Ree JM; Westenberg HG; Krul JM; Brouwer GJ; Thijssen JH; de Wied D; van Praag HM; Ceulemans DL; Kahn RS
    Psychiatry Res; 1984 Apr; 11(4):329-46. PubMed ID: 6204351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of des-tyrosyl-gamma-endorphin in mental illness.
    Emrich HM; Zaudig M; Kissling W; Dirlich G; von Zerssen D; Herz A
    Ann N Y Acad Sci; 1982; 398():470-7. PubMed ID: 6760770
    [No Abstract]   [Full Text] [Related]  

  • 6. Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients.
    Emrich HM; Zaudig M; Kissling W; Dirlich G; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):290-8. PubMed ID: 7003611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic effect of gamma-type endorphins in schizophrenia.
    van Ree JM; de Wied D; Verhoeven WM; van Praag HM
    Lancet; 1980 Dec 20-27; 2(8208-8209):1363-4. PubMed ID: 6109172
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE).
    Verhoeven WM; van Praag HM; van Ree JM; de Wied D
    Arch Gen Psychiatry; 1979 Mar; 36(3):294-8. PubMed ID: 369471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 11. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

  • 13. (Des-Tyr)-gamma-endorphin in the treatment of schizophrenia.
    Manchanda R; Hirsch SR
    Psychol Med; 1981 May; 11(2):401-4. PubMed ID: 6115439
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endorphins of the gamma type in the treatment of schizophrenic psychoses].
    Verhoeven WM; Van Ree JM
    Acta Psychiatr Belg; 1984; 84(2):160-72. PubMed ID: 6204507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-lived effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Volavka J; Hui KS; Anderson B; Nemes Z; O'Donnell J; Lajtha A
    Psychiatry Res; 1983 Dec; 10(4):243-52. PubMed ID: 6583715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, electrophysiological, and biochemical effects of des-tyrosine-gamma-endorphin in psychiatric patients.
    Metz J; Busch DA; Meltzer HY
    Ann N Y Acad Sci; 1982; 398():496-508. PubMed ID: 6961867
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM; Verhoeven WM; Van Praag HM; De Wied D
    Mod Probl Pharmacopsychiatry; 1981; 17():266-78. PubMed ID: 6173744
    [No Abstract]   [Full Text] [Related]  

  • 18. (Des-Tyr)gamma-endorphin for schizophrenia. A critical review.
    Manchanda R; Hirsch SR
    Int Pharmacopsychiatry; 1982; 17(3):147-52. PubMed ID: 6128328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia.
    Casey DE; Korsgaard S; Gerlach J; Jørgensen A; Simmelsgaard H
    Arch Gen Psychiatry; 1981 Feb; 38(2):158-60. PubMed ID: 7011248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for evaluating improvement in schizophrenia in psychopharmacological research (with special reference to gamma endorphin fragments).
    Manchanda R; Hirsch SR; Barnes TR
    Br J Psychiatry; 1988 Sep; 153():354-8. PubMed ID: 3250672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.